Accepted for publication: Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization

Menlo Park, CA, USA November 3, 2009–A manuscript titled “Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli managed healthcare organization,” co-authored by John Hornberger, MD, MS and Julie Doberne with Shmuel Klang, PhD has been accepted by Value In Health for publication.